Passie T, Seifert J, Schneider U, Emrich HM (2002). "The pharmacology of psilocybin". Addiction Biology. 7 (4): 357–64. doi:10.1080/1355621021000005937. PMID 14578010.
↑ Merck Index, 11th Edition, 7942
Wurst M, Kysilka R, Flieger M (2002). "Psychoactive tryptamines from Basidiomycetes". Folia Microbiologica. 47 (1): 3–27. doi:10.1007/BF02818560. PMID 11980266.
Shirota O, Hakamata W, Goda Y (2003). "Concise large-scale synthesis of psilocin and psilocybin, principal hallucinogenic constituents of "magic mushroom"". Journal of Natural Products. 66 (6): 885–7. doi:10.1021/np030059u. PMID 12828485.
"Psilocybine". Hazardous Substances Data Bank. U.S. National Library of Medicine. สืบค้นเมื่อ November 21, 2011.
"What are the short-term effects of psilocybin mushrooms?". Drug Policy Alliance. สืบค้นเมื่อ June 27, 2019.
"Earliest evidence for magic mushroom use in Europe". New Scientist. March 2, 2011. สืบค้นเมื่อ June 27, 2019.
"Psilocybin". Usona Institute. สืบค้นเมื่อ June 27, 2019.
"Psilocybin". Alcohol and Drug Foundation. สืบค้นเมื่อ June 27, 2019.
"What are magic mushrooms and psilocybin?". Medical News Today. สืบค้นเมื่อ June 27, 2019.
"List of Psychotropic Substances Under International Control" (PDF). International Narcotics Control Board. สืบค้นเมื่อ June 27, 2019.
"เห็ดขี้ควาย". กองควบคุมวัตถุเสพติด. สืบค้นเมื่อ June 27, 2019.
ไซโลไซบ, งกฤษ, psilocybin, เป, นสารหลอนประสาทท, พบในกล, มเห, ดกว, ชน, โดยเฉพาะเห, ดสก, psilocybe, เป, นสารแอลคาลอยด, ตรเคม, c12h17n2o4p, ละลายในน, เมทานอลและเอทานอล, ไม, ละลายในต, วทำละลายอ, นทร, เช, คลอโรฟอร, มและป, โตรเล, ยมอ, เทอร, บร, ทธ, กษณะเป, นผล, กร, . isolisbin xngkvs psilocybin epnsarhlxnprasaththiphbinklumehdisolisbinkwa 200 chnid odyechphaaehdskul Psilocybe isolisbinepnsaraexlkhalxydthimisutrekhmikhux C12H17N2O4P lalayinna emthanxlaelaexthanxl imlalayintwthalalayxinthriy echn khlxorfxrmaelapiotreliymxiethxr 3 isolisbinbrisuththimilksnaepnphlukrupekhmsikhaw klinkhlayaexmomeniyxxn 4 5 micudhlxmehlwpraman 220 228 s isolisbinsngphltxcitprasathkhlaykbaexlexsdi emskhalinaeladiexmthi xakarthwipidaek phawaekhlimsukh prasathhlxnaelakarrbruthiphidephiyn xacmixakarkhangekhiyng echn khlunishruxtuntrahnk 6 isolisbinchuxtam IUPAC 3 2 Dimethylaminoethyl 1H indol 4 yl dihydrogen phosphateelkhthaebiynelkhthaebiyn CAS 520 52 5 CAS PubChem 10624EC number 208 294 4KEGG C07576MeSH PsilocybineChEBI 8614RTECS number NM3150000SMILES CN C CCC1 CNC2 C1C CC C2 OP O O OInChI 1 C12H17N2O4P c1 14 2 7 6 9 8 13 10 4 3 5 11 12 9 10 18 19 15 16 17 h3 5 8 13H 6 7H2 1 2H3 H2 15 16 17 Beilstein Reference 273158ChemSpider ID 10178PharmacologyRoutes ofadministration pak hlxdeluxddaMetabolism tbEliminationhalf life pak 163 64 nathihlxdeluxdda 74 1 19 6 nathi 1 Eliminationhalf life itLegal status Prohibited S9 AU Schedule III CA Class A UK Schedule I US khunsmbtisutromelkul C12H17N2O4Pmwlomelkul 284 25 g mol 1cudhlxmehlw 220 228 C 428 442 F 2 khwamsamarthlalayid in na lalaykhwamsamarthlalayid lalayinemthanxl lalayidbanginexthanxl lalayidelknxyinkhlxorfxrmaelaebnsinkhwamxntrayLD50 285 mg kg mouse i v 280 mg kg rat i v 12 5 mg kg rabbit i v 2 hakmiidrabuepnxun khxmulkhangtnnikhuxkhxmulsar n phawamatrthanthi 25 C 100 kPasthaniyxy ekhmimihlkthanphaphwadbnhininpraethssepnaelaaexlcieriythiaesdngihehnwamnusyichisolisbinmatngaetsmykxnprawtisastr 7 inemosxemrika mikarichisolisbininphithikrrmthangcitwiyyan inpi kh s 1959 xlebirt hxfmann nkekhmikhxngbristhyaaesndxs skdisolisbincakehdchnid Psilocybe mexicana thaihmikarichisolisbinknxyangaephrhlayinewlatxma 8 isolisbinxxkvththitxbukhkhlaetktangkn odykhunxyukbchnidkhxngehd primanaelasrirwithyakhxngphuidrb 9 chwngthswrrsthi 1960 thiomthi eliyri nkcitwithyaaehngmhawithyalyharwardthakarthdlxngcnphbwa emuxisolisbinekhasurangkaycaepliynrupepnisolsin sungsngphltxtwrbesorothnininsmxngthikhwbkhumxarmnaelakarrbru odythwip isolisbincaxxkvththinan 2 6 chwomnghruxxacnankwannenuxngcakisolisbinsngphlihkarrbruewlaphidephiyn 10 karkhrxbkhrxngisolisbinthuxepnkhwamphidinhlaypraeths khnakrrmkarkhwbkhumyaesphtidrahwangpraethscdisolisbinxyuinsarkhwbkhumpraephth 1 11 sahrbpraethsithycdisolisbinxyuinwtthuxxkvththipraephth 1 tamphrarachbyytiwtthuthixxkvththitxcitaelaprasath ph s 2518 12 khxmmxns miphaphaelasuxekiywkb isolisbinxangxing aekikh Passie T Seifert J Schneider U Emrich HM 2002 The pharmacology of psilocybin Addiction Biology 7 4 357 64 doi 10 1080 1355621021000005937 PMID 14578010 2 0 2 1 Merck Index 11th Edition 7942 Wurst M Kysilka R Flieger M 2002 Psychoactive tryptamines from Basidiomycetes Folia Microbiologica 47 1 3 27 doi 10 1007 BF02818560 PMID 11980266 Shirota O Hakamata W Goda Y 2003 Concise large scale synthesis of psilocin and psilocybin principal hallucinogenic constituents of magic mushroom Journal of Natural Products 66 6 885 7 doi 10 1021 np030059u PMID 12828485 Psilocybine Hazardous Substances Data Bank U S National Library of Medicine subkhnemux November 21 2011 What are the short term effects of psilocybin mushrooms Drug Policy Alliance subkhnemux June 27 2019 Earliest evidence for magic mushroom use in Europe New Scientist March 2 2011 subkhnemux June 27 2019 Psilocybin Usona Institute subkhnemux June 27 2019 Psilocybin Alcohol and Drug Foundation subkhnemux June 27 2019 What are magic mushrooms and psilocybin Medical News Today subkhnemux June 27 2019 List of Psychotropic Substances Under International Control PDF International Narcotics Control Board subkhnemux June 27 2019 ehdkhikhway kxngkhwbkhumwtthuesphtid subkhnemux June 27 2019 bthkhwamekiywkbekhminiyngepnokhrng khunsamarthchwywikiphiediyidodyephimkhxmul duephimthi sthaniyxy ekhmiekhathungcak https th wikipedia org w index php title isolisbin amp oldid 8370838, wikipedia, วิกิ หนังสือ, หนังสือ, ห้องสมุด,